Haoxi Health Technology Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HAO research report →
Price Chart
About the company
Haoxi Health Technology Limited, operating with its subsidiaries in China, specializes in providing digital marketing services. The company's offerings encompass online short video marketing, which it delivers to advertisers through its network of media partners, alongside custom-designed marketing strategies. These tailored solutions involve the careful planning, creation, distribution, and optimization of online advertisements across various digital platforms, all aimed at helping advertisers attract new customers, drive conversions, and cultivate consumer loyalty.
- CEO
- Zhen Fan
- IPO
- 2024
- Employees
- 28
- HQ
- Beijing, BJ, CN
Get TickerSpark's AI analysis on HAO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $875.58K
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.02
- P/B
- 0.00
- EV/EBITDA
- 1.09
- Div Yield
- 0.00%
- Gross Margin
- 1.15%
- Op Margin
- -14.88%
- Net Margin
- -17.39%
- ROE
- -56.40%
- ROIC
- -41.91%
Latest fiscal year · YoY change
- Revenue
- $54.83M+67.1%
- Gross Profit
- $629.09K-32.2%
- Op Income
- $-8,160,043
- Net Income
- $-9,536,245-346.0%
- EPS
- $-7727.91-23376.8%
- OCF Growth
- +23.5%
- FCF Growth
- +23.5%
- 52W High
- $4352.00
- 52W Low
- $2.37
- 50D MA
- $3.11
- 200D MA
- $1434.53
- Beta
- -1.25
- RSI (14)
- 26
- Avg Volume
- 399.22K
No earnings-call transcripts are available for HAO yet.
- Free Float
- 99.8%
- Shares Outstanding
- 350.23K
- Float Shares
- 349.70K
of shares held by institutions
5 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 19, 26 | Fan Zhen | buy | 40,000,000 |
| Mar 18, 26 | Xu Lei LX | other | 0 |
| Mar 18, 26 | Su Changmao | other | 0 |
| Mar 18, 26 | Fan Zhen | other | 0 |
| Mar 18, 26 | Li Dongxue | other | 0 |
| Mar 18, 26 | Hu Chuanjie | other | 0 |
| Mar 18, 26 | Liu Jia | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our HAO coverage
Recent articles, reports, and earnings notes.
No research on HAO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HAO report →Haoxi Health Technology Limited Announces 1-For-20 Reverse Share Split
globenewswire.com · Aug 12
Haoxi Health Technology Limited (NASDAQ:HAO) Short Interest Up 810.7% in July
defenseworld.net · Jul 27
Haoxi Health Technology Limited Announces Strategic Cooperation Framework with NOVA MEDIA to Develop An AI Digital Marketing System
globenewswire.com · Jul 14
Univest Securities, LLC Announces Closing of $4 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)
globenewswire.com · Jul 13
Univest Securities, LLC Announces Closing of $4 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)
globenewswire.com · Jul 13
Haoxi Health Technology Ltd Announces $4 Million Registered Direct Offering
globenewswire.com · Jul 10
Haoxi Health Technology Limited Announces 1-For-128 Reverse Share Split
globenewswire.com · May 19
Univest Securities, LLC Announces Closing of $6.5 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)
globenewswire.com · May 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.